Effective Oct. 1, 2026, we will no longer cover glucagon-like peptide-1 medications (GLP-1s) when used for weight loss for Tufts Health RITogether members. Prior authorizations beyond Oct. 1 will be end-dated and the members will be notified of the change in coverage. 

Look to future issues of Insights and Updates for Providers for more information, as we intend to share further details upon receipt of additional direction from the Rhode Island Executive Office of Health and Human Services.